Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

ZYXI - ZYNEX INC


IEX Last Trade
8.19
0   0%

Share volume: 0
Last Updated: Fri 20 Dec 2024 09:14:26 PM CET
Surgical and Medical Instrument Manufacturing : 0.39%

PREVIOUS CLOSE
CHG
CHG%

$8.19
0.25
0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
64%
Profitability 62%
Dept financing 48%
Liquidity 58%
Performance 73%
Company vs Stock growth
vs
Performance
5 Days
-2.37%
1 Month
1.73%
3 Months
3.38%
6 Months
-8.33%
1 Year
-21.80%
2 Year
-40.00%
Key data
Stock price
$8.19
P/E Ratio 
41.33
DAY RANGE
$8.19 - $8.44
EPS 
$0.18
52 WEEK RANGE
$7.50 - $13.77
52 WEEK CHANGE
-$22.46
MARKET CAP 
249.496 M
YIELD 
N/A
SHARES OUTSTANDING 
31.743 M
DIVIDEND
$0.10
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
10/24/2024
BETA 
0.88
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$100,647
AVERAGE 30 VOLUME 
$70,497
Company detail
CEO: Thomas Sandgaard
Region: US
Website: zynex.com
Employees: 770
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body.

Recent news